Other Assets, Noncurrent in USD of RIGEL PHARMACEUTICALS INC from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
RIGEL PHARMACEUTICALS INC quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • RIGEL PHARMACEUTICALS INC Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $1.17M, a 75.5% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.17M -$3.59M -75.5% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $4.18M -$551K -11.6% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $1.52M -$2.8M -64.9% 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $1.44M -$1.62M -53% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $4.76M -$195K -3.94% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $4.74M +$4.19M +775% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $4.32M +$3.78M +697% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $3.06M +$2.42M +377% 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 $4.96M +$4.47M +924% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $541K +$138K +34.2% 30 Jun 2023 10-Q 01 Aug 2023
Q1 2023 $542K +$78K +16.8% 31 Mar 2023 10-Q 02 May 2023
Q4 2022 $640K -$334K -34.3% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $484K -$451K -48.2% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $403K -$437K -52% 30 Jun 2022 10-Q 02 Aug 2022
Q1 2022 $464K -$354K -43.3% 31 Mar 2022 10-Q 03 May 2022
Q4 2021 $974K +$150K +18.2% 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 $935K +$115K +14% 30 Sep 2021 10-Q 02 Nov 2021
Q2 2021 $840K +$187K +28.6% 30 Jun 2021 10-Q 03 Aug 2021
Q1 2021 $818K +$157K +23.8% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $824K +$128K +18.4% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $820K +$125K +18% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $653K -$60K -8.42% 30 Jun 2020 10-Q 04 Aug 2020
Q1 2020 $661K -$68K -9.33% 31 Mar 2020 10-Q 05 May 2020
Q4 2019 $696K -$39K -5.31% 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 $695K +$43K +6.6% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $713K +$35K +5.16% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $729K -$25K -3.32% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $735K -$68K -8.47% 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 $652K -$118K -15.3% 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $678K -$26K -3.69% 30 Jun 2018 10-Q 08 Aug 2018
Q1 2018 $754K +$24K +3.29% 31 Mar 2018 10-Q 01 May 2018
Q4 2017 $803K +$39K +5.11% 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 $770K -$30K -3.75% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 $704K -$138K -16.4% 30 Jun 2017 10-Q 01 Aug 2017
Q1 2017 $730K -$334K -31.4% 31 Mar 2017 10-Q 02 May 2017
Q4 2016 $764K -$346K -31.2% 31 Dec 2016 10-K 06 Mar 2018
Q3 2016 $800K -$373K -31.8% 30 Sep 2016 10-Q 01 Nov 2016
Q2 2016 $842K -$179K -17.5% 30 Jun 2016 10-Q 02 Aug 2016
Q1 2016 $1.06M +$3K +0.28% 31 Mar 2016 10-Q 03 May 2016
Q4 2015 $1.11M +$21K +1.93% 31 Dec 2015 10-K 07 Mar 2017
Q3 2015 $1.17M -$241K -17% 30 Sep 2015 10-Q 03 Nov 2015
Q2 2015 $1.02M -$440K -30.1% 30 Jun 2015 10-Q 04 Aug 2015
Q1 2015 $1.06M -$423K -28.5% 31 Mar 2015 10-Q 07 May 2015
Q4 2014 $1.09M -$439K -28.7% 31 Dec 2014 10-K 08 Mar 2016
Q3 2014 $1.41M -$172K -10.8% 30 Sep 2014 10-Q 04 Nov 2014
Q2 2014 $1.46M -$183K -11.1% 30 Jun 2014 10-Q 05 Aug 2014
Q1 2014 $1.48M -$217K -12.8% 31 Mar 2014 10-Q 07 May 2014
Q4 2013 $1.53M -$231K -13.1% 31 Dec 2013 10-K 03 Mar 2015
Q3 2013 $1.59M -$240K -13.1% 30 Sep 2013 10-Q 05 Nov 2013
Q2 2013 $1.64M -$231K -12.3% 30 Jun 2013 10-Q 06 Aug 2013
Q1 2013 $1.7M -$231K -12% 31 Mar 2013 10-Q 07 May 2013
Q4 2012 $1.76M -$232K -11.7% 31 Dec 2012 10-K 04 Mar 2014
Q3 2012 $1.83M -$224K -10.9% 30 Sep 2012 10-Q 06 Nov 2012
Q2 2012 $1.88M -$255K -12% 30 Jun 2012 10-Q 07 Aug 2012
Q1 2012 $1.93M 31 Mar 2012 10-Q 01 May 2012
Q4 2011 $1.99M -$244K -10.9% 31 Dec 2011 10-K 05 Mar 2013
Q3 2011 $2.05M 30 Sep 2011 10-Q 01 Nov 2011
Q2 2011 $2.13M 30 Jun 2011 10-Q 02 Aug 2011
Q4 2010 $2.24M 31 Dec 2010 10-K 06 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.